Delivery Order SPE2DB20D7066-SPE2DB25FC4UU
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Estring 7.5 mcg/day contraceptive vaginal rings with a ceiling value of $1,374.48. This firm fixed-price delivery order, with an ultimate completion date of August 27, 2025, represents a non-competitive set-aside transaction under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $4,856.86 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Estring 7.5 mcg/day (2mg) contraceptive vaginal rings. This is a non-set-aside competitive award with an ultimate completion date of August 25, 2025, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,374.48 to AmerisourceBergen Drug Corp for Estring 7.5 microgram per day contraceptive rings (2 milligram dosage) on June 30, 2025, with completion scheduled for July 1, 2025. This non-compete, firm fixed price delivery order will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under AmerisourceBergen's existing indefinite delivery...
- The Defense Logistics Agency awarded a $2,944.85 delivery order to AmerisourceBergen Drug Corp for Estring 7.5 micrograms/day contraceptive rings (2 mg dosage). This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of July 1, 2025. The award was issued on June 30, 2025, with performance to take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $2,690.34 firm fixed price delivery order to AmerisourceBergen Drug Corp for Estring 7.5 mcg/day contraceptive rings (2mg dosage) on August 26, 2025, with completion scheduled for August 27, 2025. The contract was awarded without a set-aside designation through open competition and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction within AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,741.68 firm fixed price delivery order to AmerisourceBergen Drug Corp for Estring 7.5 mcg/day (2mg) vaginal rings on July 29, 2025, with an ultimate completion date of July 30, 2025. This non-competitive delivery order represents a pharmaceutical supply transaction executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026....
- This delivery order awards AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, a contract valued at $4,645.68 for Estring 7.5 mcg/day (2 mg) contraceptive vaginal rings. The award is a firm fixed price delivery order with no set-aside designation, issued under a competitive process by the Defense Logistics Agency's Medical Supply Chain. The ultimate completion date is September 19, 2025, with the work performed at the contractor's...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for Estring 7.5 mcg/day (2 mg) contraceptive vaginal rings with a ceiling value of $3,289.23. This firm fixed-price delivery order is non-competitive and utilizes no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,325.72 firm fixed-price delivery order is for the supply of ESTRING 7.5 MCG/DAY (2MG) RINGS, a vaginal estrogen medication. The contract has a period of performance through November 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- Amerisourcebergen Drug Corp, through its Corporate Office division, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to supply ESTRING 7.5 MCG/DAY (2MG) RINGS. The contract has a potential value of $2,386.41 and a completion date of February 12, 2024. This order is part of Amerisourcebergen's larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, to provide pharmaceutical products and medical supplies to DLA Troop Support Medical...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4UUDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,290.80 to AmerisourceBergen Drug Corp for Estring 7.5 mcg/day (2 mg) contraceptive vaginal rings. The contract, issued on September 18, 2025, with completion targeted for September 19, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfills this order under its larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. This delivery order is part of AmerisourceBergen Drug Corp's comprehensive pharmaceutical supply role supporting federal medical procurement, particularly for military and veteran healthcare systems. As a major pharmaceutical distributor, the company leverages its prime IDC vehicle to supply a wide range of medications and medical products to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities globally. The Estring delivery represents a routine pharmaceutical commodity supply within the company's extensive portfolio of brand-name and generic medications supporting diverse therapeutic domains across the federal health system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/18/25 |